13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 41 holding rows worth $1,294,170,939.
- Accession
- 0000950123-23-007714
- Filer
- CIK 1388325
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 41 entries on the cover page, a total value of $1,294,170,939 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,294,170,937 with VALUE read as dollars as filed, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHS | N07059210 | STOK | 197,760 | $143,326,560 | dollars as filed | |
| Salesforce.com, Inc | 79466L302 | COM | 530,500 | $112,073,430 | dollars as filed | |
| LANZATECH GLOBAL INC | 51655R101 | COM | 15,814,845 | $108,015,391 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 3,377,768 | $75,155,338 | dollars as filed | |
| TAIWAN SEMICONDUCTOR MFG | 874039100 | SPONSORED ADS | 710,780 | $71,731,918 | dollars as filed | |
| CABLE ONE INC | 12685J105 | COM | 94,103 | $61,833,199 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,090,772 | $48,430,293 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 6,071,703 | $47,055,698 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 1,684,193 | $43,570,073 | dollars as filed | |
| Apple Inc | 037833100 | COM | 221,460 | $42,956,596 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 845,000 | $42,199,300 | dollars as filed | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 500,827 | $41,743,930 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 400,000 | $34,672,000 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 1,000,000 | $31,620,000 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 159,986 | $30,790,906 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 448,804 | $28,364,413 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,339,304 | $28,259,314 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,095,900 | $26,324,504 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 118,383 | $22,485,667 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,000,000 | $21,900,000 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 3,330,377 | $21,847,273 | dollars as filed | |
| BROOKFIELD ASSET MANAGEMENT IN | 112585104 | CL A LTD VT SH | 627,207 | $20,465,764 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,329,325 | $20,125,981 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,100,000 | $19,822,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 920,000 | $18,280,400 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,000,000 | $18,070,000 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 6,722,336 | $14,453,022 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 2,187,999 | $12,384,074 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 333,884 | $10,847,891 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 32,500 | $10,550,800 | dollars as filed | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 3,662,636 | $9,522,854 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 500,000 | $9,375,000 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 360,000 | $9,208,800 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 1,126,915 | $7,279,871 | dollars as filed | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 2,100,000 | $6,552,000 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 3,277,932 | $6,408,357 | dollars as filed | |
| GALECTO INC | 36322Q107 | COM | 2,497,791 | $6,294,433 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 2,400,000 | $4,872,000 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 815,707 | $2,471,592 | dollars as filed | |
| MARQETA INC | 57142B104 | CLASS A COM | 441,558 | $2,150,387 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 468,902 | $679,908 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-007714 | this filing | 2023-08-14 | acceptance time not in the bulk data set |